Sanofi Consumer Healthcare India Limited Reports Revenue Growth and Strategic Updates
Sanofi Consumer Healthcare India Limited reported ₹8784 million in revenue from operations for FY 2025. The company’s operating profit increased by 13%, and profit after tax rose by 33%.The company has undergone several significant changes recently, including investments curtailed in 2021, a hived-off Nutra business, a demerger finalized in June 2024, voluntary recalls in July 2024, and a successful listing on the exchange in September 2024. A new identity and workplace were established in December 2024, followed by relaunches of DePURA 60k, Combiflam suspension, Allegra, and DePURA Kids throughout 2025.In March 2026, the company hired 60 new...